ArticleMolecular therapy. Oncology2025

Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML.

Franco Bernasconi-Bisio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.